Skip to main content

Day: January 25, 2022

Icanic Brands Announces Definitive Agreement to Acquire 100% of LEEF Holdings, California’s Premier Extraction Company

VANCOUVER, British Columbia, Jan. 25, 2022 (GLOBE NEWSWIRE) — Icanic Brands Company, Inc. (CSE: ICAN, OTCQB: ICNAF) (“Icanic Brands” or the “Company”), a multi-state brand operator of premium Cannabis brands in California and Nevada, is pleased to announce that the Company has entered into a definitive agreement (the “Agreement”) with LEEF Holdings, Inc. (“LEEF”), a California based extractions company (the “Acquisition”). LEEF is one of the largest cannabis extraction companies in the state of California and is a leading provider of bulk concentrates to many of the largest brands in the state. It is led by an expert group of legacy operators with decades of experience in organic soil-based farming and sophisticated extraction practices. LEEF’s manufacturing capabilities include a 12,000 sq.ft state of the art extraction and manufacturing...

Continue reading

Islandsbanki hf.: Result of tender offer

Íslandsbanki hereby announces the results of its invitation to holders of its outstanding €300,000,000 1.125 per cent. Notes due 12 April 2022 to tender their Notes for purchase by the Offeror for cash. The Offer was announced on 17 January 2022 and was made on the terms and subject to the conditions contained in the tender offer memorandum dated 17 January 2022 prepared by the Bank. The Bank received valid tenders of €199,916,000 which were all accepted. Dealer managers for the transaction were: BofA Securities, Deutsche Bank, Morgan Stanley and Nomura. For further information:Investor Relations: ir@islandsbanki.is.

Continue reading

Aurora Spine Announces Initial Surgeries Using its Proprietary APOLLOTM Cervical Plate

CARLSBAD, Calif., Jan. 25, 2022 (GLOBE NEWSWIRE) — Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, announced today that the first anterior cervical discectomy and fusion procedures were completed with its proprietary APOLLOTM Anterior Cervical Plate (ACP) system and implanted in multiple patients by Dr. Sebastian Koga, a neurosurgeon at Koga Neurosurgery based in Covington, Louisiana.  APOLLO one of Aurora’s recent FDA 510(k) cleared products and provides new technology-based options to patients and surgeons in spine surgery. The APOLLO System features streamlined instrumentation and high angulation-option screws to help surgeons perform the procedure while preserving the patient’s skeletal and...

Continue reading

Coloplast A/S – Allocation of Share Options

Report on transactions of executives and related parties in Coloplast shares and related securities According to the Market Abuse Regulation article 19 Coloplast is obliged to report on the transactions of executives and their related parties in Coloplast shares and related securities. The below transactions concern allocation of share options. For further details, reference is made to Coloplast’s Remuneration Policy which was adopted in 2021. The policy is available on the group website at this address:https://investor.coloplast.com/investor-relations/governance/policies_and_positions/1 Details of the person discharging managerial responsibilities/person closely associateda) Name Kristian Villumsen2 Reason for the notificationa) Position/status President & CEOb) Initial notification/Amendment Initial notification3 Details...

Continue reading

OraSure Technologies, Inc. Expands HIV Oral Swab In-home Test into Europe

BETHLEHEM, Pa., Jan. 25, 2022 (GLOBE NEWSWIRE) —  OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies, announced today that it has launched its OraQuick® HIV Self-Test, an oral swab in-home test for HIV-1 and HIV-2, into Europe. The test will be available in six European countries: United Kingdom, Germany, France, Italy, Spain and Portugal. “We are currently seeing an increase in HIV testing policies, as well as the rise of HIV prevalence around the globe,” said Giffin Daughtridge, MD, MBA, Senior Director of Infectious Disease Diagnostics for OraSure Technologies, Inc. “Having initially launched in the U.S. in 2012, we focused on regions in need during the last decade, distributing 76 million tests worldwide, many of which were in Sub-Saharan...

Continue reading

The proposal of Taaleri’s Shareholders’ Nomination Board for the composition and remuneration of the Board of Directors

TAALERI PLC             STOCK EXCHANGE RELEASE                25 JANUARY 2022 AT 14:00 (EET) The proposal of Taaleri’s Shareholders’ Nomination Board for the composition and remuneration of the Board of Directors Proposal for the composition of the Board of Directors Taaleri’s Shareholders’ Nomination Board proposes to the next Annual General Meeting, which is planned to be held on 6 April 2022, that the number of members of the Board of Directors for the term expiring at the close of the Annual General Meeting 2022 will be six (6), and that Juhani Elomaa, Hanna Maria Sievinen, Tuomas Syrjänen, Elina Björklund and Petri Castrén are re-elected as Board members and Jouni Takakarhu is elected as new member of the Board, Juhani Elomaa is elected as the Chairperson of the Board and Hanna Maria Sievinen as the Deputy Chairperson...

Continue reading

View Smart Windows to be Featured in Seattle-Area Skanska Office Project

The Eight, a high-rise office tower in the Seattle market developed by SkanskaView smart windows will be featured in The Eight, a Class-A high-rise office tower developed by Skanska, one of the first buildings in the Bellevue Central Business District to feature smart windows.MILPITAS, Calif. and BELLEVUE, Wash., Jan. 25, 2022 (GLOBE NEWSWIRE) — View, Inc. (NASDAQ: VIEW) (“View”), the leader in smart building technologies, has been selected by global construction and development leader Skanska to be featured in The Eight, a Class-A high-rise office tower and one of the first buildings in the Bellevue Central Business District to feature smart windows. Built, developed, and owned by Skanska USA Commercial Development, The Eight is a 25-story, 541,000 square-foot commercial office tower featuring retail spaces,...

Continue reading

OTC Markets Group Announces Quarterly Index Performance and Rebalancing

NEW YORK, Jan. 25, 2022 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 11,000 U.S. and global securities, today announced the fourth quarter 2021 performance and quarterly rebalancing of the OTCQX® and OTCQB® indexes, including the OTCQX Canada Index and the OTCQX Dividend Index. The OTCQX Composite Index (.OTCQX), a benchmark for the overall OTCQX Best Market, was up 3.5% in the fourth quarter. Forty-one new companies were added to the index, including: CIB Marine Bancshares, Inc. (OTCQX: CIBH); E3 Metals Corp (OTCQX: EEMMF); T Stamp Inc. (OTCQX: IDAI); PROSTAR HLDGS INC. (OTCQX: MAPPF); Starr Peak Mining Ltd. (OTCQX: STRPF) and Grayscale Zcash Trust (ZEC) (OTCQX ZCSH). Forty-seven were removed from the index including: Skeena Resources Limited (SKE) which graduated to the NYSE. Augmedix,...

Continue reading

Athira Pharma Announces Initiation of Patient Dosing in SHAPE, a Phase 2 Clinical Trial of ATH-1017 for the Treatment of Parkinson’s Disease Dementia and Dementia with Lewy Bodies

BOTHELL, Wash., Jan. 25, 2022 (GLOBE NEWSWIRE) — Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and stop neurodegeneration, today announced that patient dosing has begun in SHAPE, a Phase 2 clinical trial of ATH-1017 for the treatment of Parkinson’s disease dementia and Dementia with Lewy bodies. ATH-1017 is a small molecule designed to enhance the activity of Hepatocyte Growth Factor (HGF) and its receptor, MET, to impact neurodegeneration and regenerate brain tissue. “The initiation of SHAPE is an important milestone in the advancement of our clinical development of ATH-1017. This small molecule is designed to impact neurodegeneration by focusing on network recovery and information transmission in the brain,” said Hans...

Continue reading

Green Thumb Industries to Hold Fourth Quarter and Full Year 2021 Earnings Conference Call on March 1, 2022

CHICAGO and VANCOUVER, British Columbia, Jan. 25, 2022 (GLOBE NEWSWIRE) — Green Thumb Industries Inc. (Green Thumb) (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer packaged goods company and owner of RYTHM, Dogwalkers and incredibles branded cannabis products, today announced it will hold a conference call on Tuesday, March 1, 2022, at 8:00 a.m. ET following the release of its fourth quarter and full year 2021 financial results. The earnings conference call may be accessed by dialing 844-883-3895 (Toll-Free) or 412-317-5797 (International) with conference ID: 10163013. Investors may pre-register for the call by navigating to https://dpregister.com/sreg/10163013/f0aaebb97c. A live audio webcast of the call will also be available on the Investor Relations section of Green Thumb’s website at https://investors.gtigrows.com and...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.